Form 4: Hims & Hers Health, Inc. Executive Carroll Patrick Harrison Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Chief Medical Officer Patrick Harrison Carroll reports transactions involving Hims & Hers Health, Inc. Class A Common Stock, including the vesting of Restricted Stock Units (RSUs) and shares withheld for tax obligations.
Summary
- On June 14, 2024, Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, Inc., reported changes in beneficial ownership of the company's Class A Common Stock.
- These changes involve the vesting of 12,987 Restricted Stock Units (RSUs) and the subsequent acquisition of Class A Common Stock.
- The issuer withheld 3,811 shares of Class A Common Stock to cover tax withholding obligations related to the RSU vesting at a price of $23.75.
- Following these transactions, Carroll directly owns 202,763 shares of Class A Common Stock.
- Carroll also directly owns 81,487 Restricted Stock Units (RSUs) that vest quarterly until December 15, 2026.
- Carroll also directly owns 72,594 Restricted Stock Units (RSUs) that vest quarterly until June 15, 2028.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects routine executive compensation and tax obligations.
Positives
- The vesting of RSUs indicates that Carroll is meeting the service-based requirements set by the company.
Industry Context
Tracking executive stock ownership provides insights into management's alignment with shareholder interests and the company's performance.
Comparison to Industry Standards
- Executive compensation packages often include RSUs as a way to incentivize long-term performance.
- The vesting schedules are typical for RSU grants, aligning with industry standards for retaining key personnel.
- Companies like Teladoc Health and GoodRx also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- Shareholders may view the vesting of RSUs as a positive sign, indicating that the executive is meeting performance goals.
- Employees may see this as a standard part of the company's compensation structure.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of the reported transactions (vesting of RSUs and tax withholding). |
| 06/18/2024 | Date of signature by Attorney-in-Fact. |
| 12/15/2023 | Initial vesting date for some of the RSUs. |
| 03/15/2024 | Quarterly vesting date for some of the RSUs. |
| 06/15/2024 | Quarterly vesting date for some of the RSUs. |
| 09/15/2024 | Quarterly vesting date for some of the RSUs. |
| 12/15/2024 | Quarterly vesting date for some of the RSUs. |
| 12/15/2026 | Final vesting date for some of the RSUs. |
| 06/15/2028 | Final vesting date for some of the RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.